发明名称 |
Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
摘要 |
The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma. |
申请公布号 |
US8952051(B2) |
申请公布日期 |
2015.02.10 |
申请号 |
US201012939846 |
申请日期 |
2010.11.04 |
申请人 |
Allergan, Inc. |
发明人 |
Gore Anuradha V.;Jordan Robert S.;Parashar Ajay;Pujara Chetan;Graham Richard;Lee Mu-Lan |
分类号 |
A61K31/4025;A61K9/00;A61K47/10;A61K47/26 |
主分类号 |
A61K31/4025 |
代理机构 |
|
代理人 |
Bass Jonathan Y. |
主权项 |
1. An ophthalmic formulation comprising at least one therapeutically active agent at a concentration of from 0.01 to 0.12% (w/v) in an ophthalmically acceptable liquid vehicle, wherein the active agent has the structure: or a pharmaceutically acceptable salt thereof, wherein:
A is —(CH2)6—, cis-CH2CH═CH—(CH2)3—, or —CH2C≡C—(CH2)3—, wherein one or two CH2 moieties may be substituted with S or O; orA is —(CH2)m—Ar—(CH2)o— wherein Ar is interarylene or heterointerarylene, the sum of m and o is from 1 to 4, and wherein one or two CH2 moieties are substituted with S or O;R1 is H or C1 to C6 alkyl; andB is optionally substituted aryl or optionally substituted heteroaryl. |
地址 |
Irvine CA US |